NUEVOLUTION A/S: Financial statements 2015
CVR: 26029708
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
NUEVOLUTION A/S (CVR 26029708) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 23,910,000 and a net result of DKK -43,912,000. The profit margin was -183.7%. Equity in the 2015 report amounted to DKK 41,737,000. The solvency ratio was 71.9%.
- Revenue
- DKK 23,910,000
- Gross Profit
- DKK -22,464,000
- Profit/Loss
- DKK -43,912,000
- Equity
- DKK 41,737,000
- Total Assets
- DKK 58,015,000
How creditworthy is NUEVOLUTION A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of November 9, 2015, EY Godkendt Revisionspartnerselskab has been appointed auditor of NUEVOLUTION A/S.
As of November 9, 2015, ALBJERG STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of NUEVOLUTION A/S.
As of September 2, 2015, Jeanette Marjorie Wood-Hoyle has joined the board of directors of NUEVOLUTION A/S.
As of September 2, 2015, Lars Henriksson has joined the board of directors of NUEVOLUTION A/S.
As of September 2, 2015, Jonas Karl Olof Brambeck has left the board of directors of NUEVOLUTION A/S.
As of May 13, 2015, Brian Peter Zambrowicz has left the board of directors of NUEVOLUTION A/S.
About NUEVOLUTION A/S
NUEVOLUTION A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CHEMGENE ApS. The management consists of Thomas Franch. The company is owned by Amgen, Inc.. The company has 59 employees (2018). In 2025, the company reported revenue of DKK 203,323,000 and a net result of DKK 39,754,000 compared with DKK -18,383,000 the year before. Equity in the 2025 report amounted to DKK 89,493,000.